GLP-1 Metabolic Optimization Protocol - Supplement Package
Several important safety considerations from UK SmPCs include: Pancreatitis risk : Seek immediate medical attention for severe, persistent abdominal pain Gallbladder disease : Including cholelithiasis and cholecystitis Diabetic retinopathy complications : Particularly with semaglutide in those with pre-existing retinopathy Dehydration and acute kidney injury : Possible with severe gastrointestinal side effects Hypoglycaemia : Increased risk when used with insulin or sulfonylureas (dose adjustment of these medications may be needed) Pregnancy/breastfeeding : Weight management GLP-1 agonists (Wegovy, Saxenda) are contraindicated in pregnancy and should be avoided during breastfeeding [5] [2] Regarding mental health specifically, regulatory agencies have scrutinised GLP-1 medications for potential psychiatric adverse effects
Multi-dose vials should be discarded after 20 needle punctures regardless of visual appearance, based on FDA guidelines for compounded sterile preparations
[29] Dujkov L, Makarevich AV, Olexikov L, Kuboviov E, Strejek F
These drugs didnt come out of nowhere, said Andrew Hardaway, Ph.D., a neuroscientist in the UAB Department of Psychiatry and Behavioral Neurobiology, who studies how hormones influence brain circuits that regulate appetite and reward